Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | 687,50 € | 753,63 € | 9,62 % |
| Biogen Inc. | 44 | 2 | 4 | 1 | 201,10 € | 294,45 € | 46,42 % |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | 369,45 € | 382,71 € | 3,59 % |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | 833,20 € | 957,22 € | 14,88 % |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | 121,40 € | 124,93 € | 2,91 % |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | 58,50 € | 85,64 € | 46,40 % |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | 67,50 € | 79,43 € | 17,67 % |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | 129,55 € | 137,63 € | 6,24 % |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | 0,41 € | - | - |
| Amgen Inc. | 22 | 0 | 3 | 0 | 257,85 € | 294,28 € | 14,13 % |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 3 | 0 | 76,62 € | 102,62 € | 33,93 % |
| Zoetis Inc. A | 20 | 1 | 3 | 1 | 148,92 € | 201,64 € | 35,40 % |
| AbbVie Inc. | 19 | 1 | 2 | 1 | 150,62 € | 174,43 € | 15,81 % |
| Icon plc | 18 | 0 | 6 | 0 | 283,60 € | 318,99 € | 12,48 % |
| Natural Alternat. | 18 | 1 | 1 | 0 | 5,65 € | - | - |
| Abbott Laboratories | 16 | 0 | 4 | 0 | 100,08 € | 116,81 € | 16,71 % |